APPLICATION EFFECT OF PERIPHERAL CENTRAL VEIN CATHETERISATION AND COMPLETELY IMPLANTABLE INFUSION PORT THROUGH INTERNAL JUGULAR VEIN IN CHEMOTHERAPY OF TUMOUR PATIENTS

Min Li¹, Yuting Wang², Ping Duan³, Liwei Cao⁴, Fen Ding^1*

¹Department of Emergency, Taikang Tongji (Wuhan) Hospital, Wuhan City 430050, China - ²Department of Oncology, Affiliated Hospital of Guangdong Medical University,Zhanjiang 524001,China - ³Department of Hematology and Oncology,ChangshaFirst Hospital, Changsha 410005, China - ⁴Department of Internal Medicine-Neurology,Taikang Tongji (Wuhan) Hospital, Wuhan City 430050,China

Objective: To investigate and compare the application effects of two methods of establishing a venous pathway in tumour patients undergoing chemotherapy: peripheral central vein catheterisation (PICC) and a completely implantable infusion port applied through the internal jugular vein.

Methods: From January 2016 to March 2019, 150 patients undergoing chemotherapy for malignant tumours were selected as study subjects and randomly divided into two groups. Group A was treated with peripheral central vein catheterisation during chemotherapy, and Group B was treated with completely implantable infusion port catheterisation of the internal jugular vein during chemotherapy. Then, the catheterisation time, complications and quality of life score of central vein catheterisation in the two groups were analysed.

Results: The average time of catheterisation in Group A (80.29±30.52) was shorter than in Group B (252.26±124.33), and the difference was statistically significant (t=11.633, P<0.05). The Karnofsky score of Group B (81.60 ±14.75) was higher than that of Group A (70.35±13.62), and the difference was statistically significant (t=4.853, P<0.05). The incidence of catheter-related infection in Group B was lower than in Group A, and the difference was statistically significant (χ²=5.792, P<0.05). The difference between Group B and Group B was significantly lower in Group B than in Group A, and the difference between groups was statistically significant (χ²=6.822, P<0.05).

Conclusion: Both peripheral central vein catheterisation and completely implantable infusion port through the internal jugular vein have positive effects in tumour patients with chemotherapy. The catheterisation mode of the peripheral central vein is more in line with the economic situation of the patients. However, from the perspective of the postoperative complications of the catheter and the quality of life of the patients, the completely implantable infusion port catheterisation through the internal jugular vein is superior.